Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Researc... by Jansen, Jeroen P., PhD, Fleurence, Rachael, PhD, Devine, Beth, PharmD, MBA, PhD, Itzler, Robbin, PhD, Barrett, Annabel, BSc, Hawkins, Neil, PhD, Lee, Karen, MA, Boersma, Cornelis, PhD, MSc, Annemans, Lieven, PhD, Cappelleri, Joseph C., PhD, MPH

Get full text

Current Methodological Issues in the Economic Assessment of Personalized Medicine by Annemans, Lieven, PhD, MSc, Redekop, Ken, PhD, MPH, Payne, Katherine, PhD, MSc

Get full text

Resource Use and Health Care Costs of COPD Patients at the End of Life: A Systematic Review by Faes, Kristof, MSc, De Frène, Veerle, PhD, Cohen, Joachim, PhD, Annemans, Lieven, PhD

Get full text

Economic Impact of Integrated Care Models for Patients with Chronic Diseases: A Systematic Review by Desmedt, Melissa, MSc, Vertriest, Sonja, MSc, Hellings, Johan, PhD, Bergs, Jochen, MSc, Dessers, Ezra, PhD, Vankrunkelsven, Patrik, PhD, Vrijhoef, Hubertus, PhD, Annemans, Lieven, PhD, Verhaeghe, Nick, PhD, Petrovic, Mirko, PhD, Vandijck, Dominique, PhD

Get full text

Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis by Mauskopf, Josephine A., PhD, Sullivan, Sean D., PhD, Annemans, Lieven, PhD, MSc, Caro, Jaime, MD, Mullins, C. Daniel, PhD, Nuijten, Mark, PhD, MBA, MD, Orlewska, Ewa, MD, PhD, Watkins, John, RPh, MPH, Trueman, Paul, MA, BA

Get full text

Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report o... by Faulkner, Eric, MPH, Annemans, Lieven, PhD, MSc, Garrison, Lou, PhD, Helfand, Mark, MD, MPH, Holtorf, Anke-Peggy, PhD, MBA, Hornberger, John, MD, MS, Hughes, Dyfrig, PhD, MRPharmS, Li, Tracy, PhD, Malone, Daniel, PhD, Payne, Katherine, PhD, Siebert, Uwe, MD, MPH, MSc, ScD, Towse, Adrian, MA, Veenstra, David, PhD, PharmD, Watkins, John, PharmD, MPH, BCPS

Get full text

Reflections on Market Access for Personalized Medicine: Recommendations for Europe by Payne, Katherine, PhD, MSc, BPharm, MRPharmS, Annemans, Lieven, PhD, MSc

Get full text

EQ-5D Versus SF-12 in Coronary Patients: Are They Interchangeable? by De Smedt, Delphine, MSc, Clays, Els, PhD, Annemans, Lieven, PhD, De Bacquer, Dirk, PhD

Get full text

EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics by Bueno, Héctor, MD, PhD, Danchin, Nicolas, MD, PhD, Tafalla, Mónica, MD, Bernaud, Corine, MD, Annemans, Lieven, PhD, Van de Werf, Frans, MD, PhD

Get full text

An Asian Regional Analysis of Cost-Effectiveness of Early Irbesartan Treatment versus Conventional Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in Patients wit... by Annemans, Lieven, PhD, Demarteau, Nadia, BioIr, MEPC, Hu, Shanlian, PhD, Lee, Tae-Jin, PhD, Morad, Zaher, MBBS, FRCP, Supaporn, Thanom, MD, Yang, Wu-Chang, MD, Palmer, Andrew J., BSc, MBBS

Get full text

Outcomes-based Risk-sharing Schemes: Is There a Potential Role in the Asia-Pacific Markets? by Coulton, Lisbet, BA, Annemans, Lieven, PhD, Carter, Rob, PhD, Herrera, Maya Baltazar, FASP, PhD, Thabrany, Hasbullah, MPH, DRPH, Lim, Jeremy, MBBS, MPH, MRCS (Edin), MMed (Surg), FAMS, Lee, Kenneth K.C., BS (Pharm), MPhil, PhD, Chen, Wen, PhD, Chaiyakunapruk, Nathorn, PharmD, PhD, Chern, Herng-Der, MD, PhD, Lee, Tae-Jin, PhD, Nakamura, Hiroshi, PhD, Yen-Huei Tarn, Tony, MS, PhD, Keskinaslan, Abdulkadir, MD, MBA, MPH

Get full text